By STEPHANIE CLIFFORD and MATTHEW GOLDSTEIN
The latest uproar around Martin Shkreli has nothing to do with drug prices, but allegations of fraud at a small hedge fund.
Published: December 18, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1QsUeDB
from WordPress http://ift.tt/1ZeXRye
via Hadi Aboukhater
No comments:
Post a Comment